Modalis Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,114	4,700	7,079	3,916	9,769	17,753
Market Cap Growth	-25.57%	-33.61%	80.79%	-59.92%	-44.97%	-71.84%
Enterprise Value	2,302	1,654	4,592	2,019	6,088	12,290
Last Close Price	59.00	56.00	102.00	124.00	335.00	613.00
Forward PE	-	-	-	-	43.68	17.75
PS Ratio	-	-	-	-	244.24	17752.87
PB Ratio	1.83	1.68	2.00	2.84	3.32	3.20
P/TBV Ratio	1.83	1.68	2.00	2.84	3.32	3.67
EV/Sales Ratio	-	-	-	-	152.21	12289.87
Debt / Equity Ratio	-	-	-	0.30	-	-
Net Debt / Equity Ratio	-1.01	-1.01	-1.01	-1.07	-1.00	-0.89
Net Debt / EBITDA Ratio	-	-	2.68	0.62	1.51	4.25
Net Debt / FCF Ratio	1.33	1.33	2.50	0.64	1.40	5.78
Asset Turnover	-	-	-	-	0.01	0
Quick Ratio	20.99	20.99	30.56	9.51	20.80	27.42
Current Ratio	21.58	21.58	30.92	9.88	21.71	28.15
Return on Equity (ROE)	-67.91%	-67.91%	-53.48%	-110.75%	-63.67%	-12.55%
Return on Assets (ROA)	-41.53%	-41.53%	-29.24%	-57.48%	-28.04%	-12.54%
Return on Invested Capital (ROIC)	-	-	-	-1453.99%	-666.56%	-177.13%
Return on Capital Employed (ROCE)	-78.10%	-78.10%	-37.40%	-129.70%	-69.00%	-21.00%
Earnings Yield	-42.08%	-45.79%	-18.60%	-61.06%	-27.66%	-4.16%
FCF Yield	-41.46%	-45.11%	-20.23%	-58.56%	-21.41%	-4.81%
Buyback Yield / Dilution	-67.52%	-67.52%	-48.96%	-6.39%	-1.23%	-9.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.